Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Colonic Neoplasms × 1-phenyl-3,3-dimethyltriazene × 1 year × Clear all

Sponsor

Conditions

Pleural Diseases 2 Pancreatic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Non-Muscle Invasive Bladder Neoplasms 1 Mesothelioma, Malignant 1 Keratosis, Actinic 1 Glioma 1 Glioblastoma 1 Epitheliod Malignant Pleural Mesothelioma 1 Carcinoma, Transitional Cell 1 Carcinoma, Basal Cell 1

Interventions

Oxaliplatin 29 Leucovorin 25 Fluorouracil 25 Bevacizumab 21 Cetuximab 20 Irinotecan 16 Capecitabine 15 Nivolumab 14 pembrolizumab 11 Folfox protocol 9 Magnetic Resonance Spectroscopy 8 Specimen Handling 7 Blood Specimen Collection 7 trifluridine tipiracil drug combination 6 encorafenib 6 Ipilimumab 6 regorafenib 5 fludarabine 5 Saline Solution 5 Immune Checkpoint Inhibitors 5 Gemcitabine 5 Exercise 5 Cyclophosphamide 5 Cisplatin 5 tislelizumab 4 dostarlimab 4 dehydroftorafur 4 cemiplimab 4 atezolizumab 4 Watchful Waiting 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡